Clinical Trials Browser

Phase 4 × Pancreatic Neoplasms × nimotuzumab × Clear all

NCT02945267 2016-10-26

Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic Cancer

Phase 4 Unknown

Gastrointestinal

Pancreatic Neoplasms